{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:08:43Z","timestamp":1789556923496,"version":"build-2803163510"},"reference-count":33,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: Vulvar carcinoma is a rare malignancy with approximately 3090 cases annually in Germany. Squamous cell carcinoma of the vulva (SCC) can be HPV-associated or non-HPV-associated. Surgical excision is the primary treatment, but the optimal tumor-free resection margin remains debated. This study evaluates the impact of resection margin distance on disease prognosis in SCC patients. Methods: A retrospective analysis was conducted on patients diagnosed with SCC of the vulva at the University Hospital of Cologne between 2007 and 2022. Patients with TNM stage pT1a or higher who underwent primary surgical treatment with a tumor-free resection margin status were included. The cohort of 73 patients was divided into three groups based on resection margin distance: &gt;0.01\u2013&lt;0.3 cm (Group 1), \u22650.3\u2013&lt;0.8 cm (Group 2), and \u22650.8 cm (Group 3). Statistical analyses including logrank tests were performed to assess correlations between resection margin distance and recurrence, disease-free survival (DFS), and overall survival (OS). Results: A total of 37.0% of patients were categorized into Group 1, 48.0% into Group 2, and 15.1% into Group 3. Disease recurrence occurred in 26% of patients, with rates of 31.6% in Group 1 (minimum resection margin distance), 42.1% in Group 2, and 26.3% in Group 3. The prevalence of recurrence was not dependent on resection margin distance (p = 0.28). Similarly, the prevalence of deaths was not dependent on resection margin distance (p = 0.43). Disease-free survival (DFS) and overall survival (OS) did not show significant differences between the groups (p = 0.25 and p = 0.87, respectively). Conclusions: This study found no significant impact of pathological tumor-free resection margin distance on DFS or OS in patients with SCC of the vulva. Given the heterogeneity in international guidelines and existing literature, further studies with larger patient cohorts are needed to establish definitive surgical recommendations.<\/jats:p>","DOI":"10.3390\/jcm14124057","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:54:05Z","timestamp":1749448445000},"page":"4057","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of Surgical Margin Distance on Oncologic Outcomes in Vulvar Squamous Cell Carcinoma"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7001-1969","authenticated-orcid":false,"given":"Caroline","family":"Lenz","sequence":"first","affiliation":[{"name":"Department of Gynecology and Gynecologic Oncology, Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf, University Hospital of Cologne, 50931 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4125-6048","authenticated-orcid":false,"given":"Su Ir","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital of Cologne, 50931 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mallmann","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Gynecologic Oncology, Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf, University Hospital of Cologne, 50931 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Morgenstern","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Gynecologic Oncology, Center for Integrated Oncology Aachen Bonn Cologne D\u00fcsseldorf, University Hospital of Cologne, 50931 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1458-7303","authenticated-orcid":false,"given":"Fabinshy","family":"Thangarajah","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, University Hospital of Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00404-011-1850-9","article-title":"Epidemiology of vulvar and vaginal cancer in Germany","volume":"284","author":"Dittmer","year":"2011","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/01.AOG.0000210268.57527.a1","article-title":"Trends in the incidence of invasive and in situ vulvar carcinoma","volume":"107","author":"Judson","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/01443615.2013.834310","article-title":"Trends of vulvar cancer","volume":"34","author":"Chhabra","year":"2014","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_4","unstructured":"Robert Koch Institut (2025, January 22). Zentrum f\u00fcr Krebsregisterdaten. Available online: https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Krebsarten\/Vulvakrebs\/vulvakrebs_node.html."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107302","DOI":"10.1016\/j.ypmed.2022.107302","article-title":"Trends in HPV- and non-HPV-associated vulvar cancer incidence, United States, 2001\u20132017","volume":"164","author":"Mix","year":"2022","journal-title":"Prev. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1158\/1940-6207.CAPR-22-0086","article-title":"Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001\u20132018","volume":"15","author":"Berenson","year":"2022","journal-title":"Cancer Prev. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100145","DOI":"10.1016\/j.modpat.2023.100145","article-title":"Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach","volume":"36","author":"Yang","year":"2023","journal-title":"Mod. Pathol."},{"key":"ref_8","unstructured":"AWMF (2020). S2k-Leitlinie Vulvakarzinom und Seine Vorstufen, Diagnostik und Therapie, AWMF."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/gyno.1998.5149","article-title":"Primary squamous cell cancer of the vulva: Radical versus modified radical vulvar surgery","volume":"71","author":"Magrina","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s00432-020-03263-1","article-title":"Preoperative biopsies as predictor for the necessity of inguinal lymph node surgery in squamous cell carcinoma of the vulva-a retrospective tertiary center analysis","volume":"146","author":"Pahmeyer","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s11547-022-01538-w","article-title":"Observational multicenter Italian study on vulvar cancer adjuvant radiotherapy (OLDLADY 1.2): A cooperation among AIRO Gyn, MITO and MaNGO groups","volume":"127","author":"Macchia","year":"2022","journal-title":"Radiol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1055\/a-1491-6405","article-title":"Morbidity and quality of life in patients with vulvar cancer after inguinal sentinel lymphadenectomy compared to radical inguinofemoral lymphadenectomy","volume":"60","author":"Thangarajah","year":"2021","journal-title":"Nuklearmedizin"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Zafarnia, M., Kennes, L.N., Stickeler, E., Hoff, J., and Najjari, L. (2022). Evaluation of urinary continence status and its influence on quality of life after gyneco-oncological treatment of female pelvic malignancies at an oncological center. BMC Women\u2019s Health, 22.","DOI":"10.1186\/s12905-022-01999-1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/AOG.0b013e31819b413f","article-title":"Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer","volume":"113","author":"Tantipalakorn","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2006.10.004","article-title":"Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: A multivariate analysis","volume":"104","author":"Chan","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/cncr.10969","article-title":"Vulvar carcinoma. The price of less radical surgery","volume":"95","author":"Hollema","year":"2002","journal-title":"Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3802\/jgo.2013.24.3.242","article-title":"Prognostic factors associated with local recurrence in squamous cell carcinoma of the vulva","volume":"24","author":"Iacoponi","year":"2013","journal-title":"J. Gynecol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/IGC.0b013e3181df7423","article-title":"Recurrence rate in vulvar carcinoma in relation to pathological margin distance","volume":"20","author":"Groenen","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1245\/s10434-011-1778-0","article-title":"Prognostic value of pathological resection margin distance in squamous cell cancer of the vulva","volume":"18","author":"Woelber","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2016.07.006","article-title":"Tumour-free margins in vulvar squamous cell carcinoma: Does distance really matter?","volume":"65","author":"Nooij","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejca.2016.09.038","article-title":"Role of tumour-free margin distance for loco-regional control in vulvar cancer\u2014A subset analysis of the Arbeitsgemeinschaft Gynakologische Onkologie CaRE-1 multicenter study","volume":"69","author":"Woelber","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_22","first-page":"455","article-title":"Vulval cancer: What is an adequate surgical margin?","volume":"29","author":"Balega","year":"2008","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijgo.2011.02.012","article-title":"Invasive vulvar carcinoma and the question of the surgical margin","volume":"114","author":"Palaia","year":"2011","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.6004\/jnccn.2024.0013","article-title":"Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Yashar","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","article-title":"European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer\u2014Update 2023","volume":"33","author":"Oonk","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0090-8258(90)90064-R","article-title":"Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva","volume":"38","author":"Heaps","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ygyno.2013.05.036","article-title":"Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma","volume":"130","author":"Viswanathan","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ejso.2019.07.005","article-title":"Surgical treatment of vulvar cancer: Impact of tumor-free margin distance on recurrence and survival. A multicentre cohort analysis from the francogyn study group","volume":"45","author":"Raimond","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1111\/jog.14962","article-title":"Positive surgical margin is an independent predictor of overall survival of patients with vulvar squamous cell carcinoma","volume":"47","author":"Nomura","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Taran, F.A., Pasternak, J., Staebler, A., Rohner, A., Neis, F., Engler, T., Oberlechner, E., Schonfisch, B., Juhasz-Boss, I., and Hartkopf, A.D. (2023). Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center. Cancers, 15.","DOI":"10.3390\/cancers15164110"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.ejso.2015.09.024","article-title":"How important is the pathological margin distance in vulvar cancer?","volume":"41","author":"Baiocchi","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1470-2045(18)30109-8","article-title":"Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: A single-centre, single-group, prospective trial","volume":"19","author":"Hockel","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00129-024-05229-7","article-title":"Operative Therapie des Vulvakarzinoms: Krebsfeldchirurgie vs. Standardtherapie","volume":"57","author":"Thangarajah","year":"2024","journal-title":"Die Gyn\u00e4kologie"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4057\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:48:31Z","timestamp":1760032111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,8]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jcm14124057"],"URL":"https:\/\/doi.org\/10.3390\/jcm14124057","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,8]]}}}